Clinical Trial Update: Use of Gallium-68 HA-DOTATATE PET/CT in Giant Cell Arteritis (GCA) [Phase 2]

View source ↗

Summary

Phase 2 trial update on Gallium-68 HA-DOTATATE PET/CT imaging for Giant Cell Arteritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• Gallium-68 HA-DOTATATE

Snippet

Sponsor: University of Alberta | Conditions: Giant Cell Arteritis | Phase 2 | Status: COMPLETED